Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Titel:
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Auteur:
Weber, Jeffrey S Carlino, Matteo S Khattak, Adnan Meniawy, Tarek Ansstas, George Taylor, Matthew H Kim, Kevin B McKean, Meredith Long, Georgina V Sullivan, Ryan J Faries, Mark Tran, Thuy T Cowey, C Lance Pecora, Andrew Shaheen, Montaser Segar, Jennifer Medina, Theresa Atkinson, Victoria Gibney, Geoffrey T Luke, Jason J Thomas, Sajeve Buchbinder, Elizabeth I Healy, Jane A Huang, Mo Morrissey, Manju Feldman, Igor Sehgal, Vasudha Robert-Tissot, Celine Hou, Peijie Zhu, Lili Brown, Michelle Aanur, Praveen Meehan, Robert S Zaks, Tal